Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome

International Journal of Rheumatic Diseases

Volumn 13, Issue 1, 2010, Pages 39-47

  Huo, An Ping ^a   Lin, Kuan Chia ^b   Chou, Chung Tei ^c  

^a Jen Ai General Hospital   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Anti SS A Ro; Anti SS B La; Antinuclear antibodies; Primary Sj gren's syndrome; Rheumatoid factor

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LA ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEROLOGY; SJOEGREN SYNDROME;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; BIOPSY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIP; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; SJOGREN'S SYNDROME;

EID: 75649145020     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2009.01444.x     Document Type: Article

References (25)

1. Fox RI, Stern M, Michelson P. Update in Sjögren syndrome. Curr Opin Rheumatol 2000, 12:391-8.
2. Vitali C, Bombardieri S, Moutsopoulos HM. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-7.
3. Vitali C, Bombardieri S, Moutsopoulos HM. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996, 55:116-21.
4. Vitali C, Bombardieri S, Jonsson R. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-8.
5. Manthorpe R. How should we interpret the lower lip biopsy finding in patients investigated for Sjögren's syndrome? Arthritis Rheum 2002, 47:114-15.
6. García-Carrasco M, Ramos-Casals M, Rosas J. Primary Sjögren's syndrome-Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 2002, 81:270-80.
7. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000, 29:296-304.
8. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome-Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984, 27:147-56.
9. Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial gland biopsies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1974, 37:217-29.
10. Agresti A. An Introduction to Categorical Data Analysis 1996, 34-6. John Wiley & Sons In, New York
11. Ramos-Casals M, Cervera R, Font J. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Lupus 1998, 7:202-6.
12. Tishler M, Yaron I, Shirazi I, Yaron M. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease. J Rheumatol 2001, 28:795-7.
13. Fossaluzza V, De Vita S. Clinical difference between ANA/anti-ENA positive or negative primary Sjögren's syndrome. Clin Rheumatol 1992, 11:385-7.
14. Haga HJ. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome. J Rheumatol 2002, 29:305-8.
15. Manthorpe R, Benoni C, Jacobsson L. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Ann Rheum Dis 2000, 59:54-60.
16. Syrjänen S. Age-related changes in structure of labial minor salivary glands. Age Ageing 1984, 13:159-65.
17. Scott CA, Avellini C, Desinan L. Chronic lymphocytic sialadenitis in HCV-related chronic liver disease: comparison with Sjögren's syndrome. Histopathology 1997, 30:41-8.
18. Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000, 109(12 pt 1):1170-5.
19. Schiødt M, Atkinson JC, Greenspan D. Sialochemistry in human immunodeficiency virus associated salivary gland disease. J Rheumatol 1992, 19:26-9.
20. Nagler RM, Laufer D, Nagler A. Parotid gland dysfunction in a murine model of acute graft versus host disease [aGVHD]. Head Neck 1998, 20:58-62.
21. Nessan VJ, Jacoway JR. Biopsy of minor salivary gland in the diagnosis of sarcoidosis. N Engl J Med 1979, 301:992-4.
22. Moutsopoulos HM, Zerva LV. Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome. Clin Rheumatol 1990, 9(1 suppl 1):123-30.
23. Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002, 29:938-44.
24. Fujita H, Fujihara T, Takeuchi T, Saito I, Tsubota K. Lacrimation and salivation are not related to lymphocytic infiltration in lacrimal and salivary glands in MRL lpr/lpr mice. Adv Exp Med Biol 1998, 438:941-8.
25. Nguyen KH, Brayer J, Cha S. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice. Arthritis Rheum 2000, 43:2297-306.